Alkem Labs Receives GST Demand Order of ₹5.2 Lakhs for FY22
Alkem Laboratories received a GST demand order for FY21-22 from West Bengal authorities. The demand includes ₹5.2 lakhs in GST, ₹3.89 lakhs in interest, and ₹0.62 lakhs in penalty. The company disagrees with the order and plans to appeal, stating no material financial or operational impact.
The company has explicitly stated that there is no material impact on its financial, operational, or other activities. The amount of the demand is also relatively small compared to the company's overall revenue.
The company received a GST demand order, which is a negative event. However, the company disagrees with the order and plans to contest it, and has stated that there is no material impact on its financials or operations. This mitigates the negative sentiment.
Alkem Laboratories Limited has announced that it has received an order from the Deputy Commissioner, Large Taxpayer Unit, Corporate Division, West Bengal, under the Goods and Services Tax Act, 2017. The order pertains to the Financial Year 2021-2022 and demands a Goods and Services Tax (GST) of ₹5,20,601/-, along with interest of ₹3,89,167/- and a penalty of ₹62,098/-.
The demand order primarily alleges issues related to the levy of GST under the Reverse Charge Mechanism and excess availment of Input Tax Credit. Alkem Laboratories Limited stated that it does not agree with the demand order and intends to contest it by filing an appeal.
The company has received the order on 29th December 2025. Alkem Laboratories Limited has also stated that there is no material impact on its financial, operational, or other activities, quantifiable in monetary terms, as a result of this order. The company is in the process of taking appropriate action, including filing an appeal against the order.
What to do with a filing like this
Alkem Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Alkem Laboratories Limited. Read the original for the full detail.